Viking Therapeutic (VKTX) PT Lowered to $85 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts VKTX Hot Sheet
Price: $26.38 -1.24%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 17 | New: 31
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 17 | New: 31
Join SI Premium – FREE
Truist Securities analyst Gregory Renza lowered the price target on Viking Therapeutic (NASDAQ: VKTX) to $85.00 (from $87.00) while maintaining a Buy rating.
You May Also Be Interested In
- Viking Therapeutic (VKTX) PT Lowered to $106 at Canaccord
- Morgan Stanley Downgrades NEXTDC Ltd. (NXT:AU) to Equalweight
- Moncler SpA (MONC:IM) (MONRY) PT Lowered to EUR47 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
